Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 192 | 1 | 225 | +34 |
| Shares | 92.7M | 34.4K | 109.6M | +17.0M (+18.3%) |
| Value | $1.71B | $635.7K | $1.38B | −$331.2M (−19.4%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (59)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (25)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 1,466,051 | $27.1M |
| Cowen and Company, LLC | 1,100,000 | $20.3M |
| First Turn Management, LLC | 621,306 | $11.5M |
| Great Lakes Advisors, LLC | 347,625 | $6.42M |
| Logos Global Management LP | 325,000 | $6.00M |
| WCM Investment Management, LLC | 285,665 | $5.27M |
| Norges Bank | 159,094 | $2.94M |
| Squarepoint Ops LLC | 53,039 | $979.6K |
| Harbour Capital Advisors, LLC | 53,690 | $892.9K |
| Vontobel Holding Ltd. | 37,398 | $690.7K |
| B. Metzler seel. Sohn & Co. AG | 34,418 | $635.7K |
| HRT Financial LP | 26,149 | $482.0K |
| SEI Investments Co | 17,060 | $315.0K |
| Bellevue Group AG | 9,300 | $171.8K |
| Values First Advisors, Inc. | 5,840 | $107.9K |
| Acadian Asset Management LLC | 3,553 | $65.0K |
| Leonteq Securities AG | 2,500 | $46.2K |
| Clearstead Advisors, LLC | 2,180 | $40.3K |
| Aster Capital Management (DIFC) Ltd | 1,137 | $21.0K |
| NBC Securities, Inc. | 437 | $8.00K |
| Point72 Asia (Singapore) Pte. Ltd. | 304 | $5.62K |
| Umb Bank N A | 278 | $5.13K |
| Point72 (DIFC) Ltd | 197 | $3.63K |
| Capital Analysts, LLC | 175 | $3.00K |
| Allspring Global Investments Holdings, LLC | 20 | $369 |
Not filed for Q4 2024 yet (1)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| B. Metzler seel. Sohn & Co. Holding AG | 34,418 | $635.7K |